SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002626
Filing Date
2015-11-12
Accepted
2015-11-12 16:09:04
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adms-20150930x10q.htm 10-Q 1580518
2 EX-31.1 adms-20150930ex31199a049.htm EX-31.1 10217
3 EX-31.2 adms-20150930ex312ace1e5.htm EX-31.2 10168
4 EX-32.1 adms-20150930ex321c34788.htm EX-32.1 12404
  Complete submission text file 0001558370-15-002626.txt   5972651

Data Files

Seq Description Document Type Size
5 EX-101.INS adms-20150930.xml EX-101.INS 1333115
6 EX-101.SCH adms-20150930.xsd EX-101.SCH 37756
7 EX-101.CAL adms-20150930_cal.xml EX-101.CAL 42505
8 EX-101.DEF adms-20150930_def.xml EX-101.DEF 142704
9 EX-101.LAB adms-20150930_lab.xml EX-101.LAB 400564
10 EX-101.PRE adms-20150930_pre.xml EX-101.PRE 258728
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 151224886
SIC: 2834 Pharmaceutical Preparations